Scholars Central

Conference abstractPublished 1 Oct 2012

Advances in stem cell technology-hESC-derived beta-cells as a source for diabetes therapy

Authors: Christian X. Andersson

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

D uring recent years the research development of human pluripotent stem cells has progressed vastly. Technical achievements have enabled generation of both in vitro products as well as in vivo applications. The tremendous possibilities of using stem cells in clinical therapy are promising and have created a growing interest in the pharmaceutical and biotech industry. Type 1 Diabetes (T1D) is an autoimmune disease with an activated immune destruction of the insulin-producing beta-cells in pancreas, resulting in an insufficient production of insulin and, thus, causing hyperglycemia as a consequence. These patients are normally treated with a continuous administration of insulin-related drugs. In order to cure T1D patients, transplantation of islands of the Langerhans have been successfully performed, but the shortage of pancreatic donors do not meet the demands to fully apply as a therapy for T1D patients. Nevertheless, the successfulness of these transplantations serves as a proof of concept for beta-cell replacement and a requirement of an unlimited resource of beta-cells is highly desirable. Novo Nordisk, a leader company in diabetes care, Cellectis Stem Cells, a pioneer in stem cell biotechnology, and Lunds University have since 2008 a joint program addressing the possibilities of generating insulin-producing beta-cells from human Embryonic Stem Cells (hESC). This presentation will focus on our strategy and current status of the project in differentiating hESC to beta-cells. Moreover, advancement in stem cell technology (e.g., generation, characterization, banking, mass production and differentiation) will be discussed and how this can be used for advancing also other areas of regenerative medicine.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Christian X. Andersson”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels